⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL11873947 | 0.87 | — | — | |
| Ethane SCHEMBL28257892 | 0.87 | — | — | |
| Ethane SCHEMBL905431 | 0.87 | — | — | |
| Ethane SCHEMBL2233163 | 0.87 | — | — | |
| Ethane SCHEMBL10894685 | 0.87 | — | — | |
| Ethane SCHEMBL10823097 | 0.87 | — | — | |
| Ethane SCHEMBL6928760 | 0.87 | — | — | |
| Ethane SCHEMBL29723104 | 0.87 | — | — | |
| Ethane SCHEMBL10952587 | 0.75 | — | — | |
| Ethane SCHEMBL6358321 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5962513-A | CENTRAL NERVOUS SYSTEM, PSYCHOLOGICAL DISORDERS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-10-05 | — | — | US | disclosed |
| US-5468882-A | Serotoninergic agents; central nervous system and psychological disorders | BAYER AKTIENGESELLSCHAFT (DE) | 1995-11-21 | — | — | US | disclosed |
| US-5318988-A | Treating psychoses | BAYER AKTIENGESELLSCHAFT (DE) | 1994-06-07 | — | — | US | disclosed |
| WO-1993020009-A1 | REMOVAL OF ETHYLENE FROM SILANE | ETHYL CORPORATION (US) | 1993-10-14 | — | — | WO | disclosed |
| US-5211931-A | Removal of ethylene from silane using a distillation step after separation using a zeolite molecular sieve | ETHYL CORPORATION (US) | 1993-05-18 | — | — | US | disclosed |
| EP-0260121-B1 | INOSOSE DERIVATIVES, PRODUCTION AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1993-03-10 | — | — | EP | disclosed |
| US-5034396-A | Antidepressants | ROUSSEL UCLAF (FR) | 1991-07-23 | — | — | US | disclosed |
| US-5004838-A | Inosose derivatives, production and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-04-02 | — | — | US | disclosed |
| US-4975427-A | Analgesics, anti-anoxic, and antiischemic properties | ROUSSEL UCLAF (FR) | 1990-12-04 | — | — | US | disclosed |
| US-4898986-A | Inosose derivatives, production and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-02-06 | — | — | US | disclosed |
| EP-0260121-A2 | Inosose derivatives, production and use thereof | Takeda Chemical Industries, Ltd. (JP) | 1988-03-16 | — | — | EP | disclosed |
| US-4291038-A | Cerebral vasodilating 20,21-dinoreburnamenine derivatives | ROUSSEL UCLAF (FR) | 1981-09-22 | — | — | US | disclosed |
| US-4183932-A | Fused quinazolinones and preparation thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-01-15 | — | — | US | disclosed |
| US-4035570-A | Method and catalyst for the production of high trans-polyalkadiene | PHILLIPS PETROLEUM COMPANY (US) | 1977-07-12 | — | — | US | disclosed |